T0	Participants 62 97	ischaemic ulcers of the lower limb.
T1	Participants 100 169	Scandinavian-Polish placebo controlled, randomised multicenter study.
T2	Participants 301 395	103 patients with ischaemic ulcers who were randomised to receive active treatment or placebo.